Similar articles for PMID: 25550533

Year	Number of Results
1998	1
2003	1
2004	1
2005	1
2006	1
2007	6
2008	3
2009	16
2010	15
2011	18
2012	15
2013	26
2014	20
2015	28
2016	31
2017	42
2018	39
2019	20
2020	24
2021	16

1

Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFκB signaling.

Chung SS, Vadgama JV. Chung SS, et al. Anticancer Res. 2015 Jan;35(1):39-46. Anticancer Res. 2015. PMID: 25550533 Free PMC article.

2

(-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.

Zhu BH, Chen HY, Zhan WH, Wang CY, Cai SR, Wang Z, Zhang CH, He YL. Zhu BH, et al. World J Gastroenterol. 2011 May 14;17(18):2315-25. doi: 10.3748/wjg.v17.i18.2315. World J Gastroenterol. 2011. PMID: 21633597 Free PMC article.

3

(-)-Epigallocatechin-3-gallate inhibits nasopharyngeal cancer stem cell self-renewal and migration and reverses the epithelial-mesenchymal transition via NF-κB p65 inactivation.

Li YJ, Wu SL, Lu SM, Chen F, Guo Y, Gan SM, Shi YL, Liu S, Li SL. Li YJ, et al. Tumour Biol. 2015 Apr;36(4):2747-61. doi: 10.1007/s13277-014-2899-4. Epub 2014 Dec 7. Tumour Biol. 2015. PMID: 25487615

4

Epigallocathechin gallate, polyphenol present in green tea, inhibits stem-like characteristics and epithelial-mesenchymal transition in nasopharyngeal cancer cell lines.

Lin CH, Shen YA, Hung PH, Yu YB, Chen YJ. Lin CH, et al. BMC Complement Altern Med. 2012 Oct 30;12:201. doi: 10.1186/1472-6882-12-201. BMC Complement Altern Med. 2012. PMID: 23110507 Free PMC article.

5

Epigallocatechin gallate hinders human hepatoma and colon cancer sphere formation.

Wubetu GY, Shimada M, Morine Y, Ikemoto T, Ishikawa D, Iwahashi S, Yamada S, Saito Y, Arakawa Y, Imura S. Wubetu GY, et al. J Gastroenterol Hepatol. 2016 Jan;31(1):256-64. doi: 10.1111/jgh.13069. J Gastroenterol Hepatol. 2016. PMID: 26241688

6

Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.

Ibrahim SA, Gadalla R, El-Ghonaimy EA, Samir O, Mohamed HT, Hassan H, Greve B, El-Shinawi M, Mohamed MM, Götte M. Ibrahim SA, et al. Mol Cancer. 2017 Mar 7;16(1):57. doi: 10.1186/s12943-017-0621-z. Mol Cancer. 2017. PMID: 28270211 Free PMC article.

7

Epigallocatechin-3-gallate potentiates the effect of curcumin in inducing growth inhibition and apoptosis of resistant breast cancer cells.

Wang S, Chen R, Zhong Z, Shi Z, Chen M, Wang Y. Wang S, et al. Am J Chin Med. 2014;42(5):1279-300. doi: 10.1142/S0192415X14500803. Am J Chin Med. 2014. PMID: 25242081

8

Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.

Lin C, Wang L, Wang H, Yang L, Guo H, Wang X. Lin C, et al. J Cell Biochem. 2013 Sep;114(9):2061-70. doi: 10.1002/jcb.24553. J Cell Biochem. 2013. PMID: 23553622

9

Estrogen receptor-α36 is involved in epigallocatechin-3-gallate induced growth inhibition of ER-negative breast cancer stem/progenitor cells.

Pan X, Zhao B, Song Z, Han S, Wang M. Pan X, et al. J Pharmacol Sci. 2016 Feb;130(2):85-93. doi: 10.1016/j.jphs.2015.12.003. Epub 2015 Dec 15. J Pharmacol Sci. 2016. PMID: 26810571 Free article.

10

Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.

Hu C, Li M, Guo T, Wang S, Huang W, Yang K, Liao Z, Wang J, Zhang F, Wang H. Hu C, et al. Phytomedicine. 2019 May;58:152740. doi: 10.1016/j.phymed.2018.11.001. Epub 2018 Nov 12. Phytomedicine. 2019. PMID: 31005718

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed